Khaitan & Co advised the lead investors, Capital 2B, Kotak Lifesciences Fund and Shastra VC on the deal.Avammune Biosciences Private Limited secured an investment of USD…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
